Re‐expression of micro<scp>RNA</scp>‐150 induces <scp>EBV</scp>‐positive <scp>B</scp>urkitt lymphoma differentiation by modulating c‐Myb <i>in vitro</i>

doi:10.1111/cas.12156

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Re‐expression of micro<scp>RNA</scp>‐150 induces <scp>EBV</scp>‐positive <scp>B</scp>urkitt lymphoma differentiation by modulating c‐Myb <i>in vitro</i>

25 Mar 2013

Abstract excerpt

Burkitt lymphoma (BL) is a highly aggressive B-cell lymphoma that includes two forms of BL differing in Epstein-Barr virus (EBV) infection status, EBV-positive and EBV-negative. Although many efforts, such as high-intensity, short-duration combination chemotherapy, have been devoted to improving therapy for this rapidly proliferating neoplasm, there are still significant treatment-associated toxicities....

Source

Open in PubMed

Identifiers

PMID: 23521217
DOI: 10.1111/cas.12156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics